Hong Kong stocks strengthened their innovative drug concept. Cansino Biotech rose more than 10%, Jingtai Holdings rose more than 4%, and Pharmacom Kangde and Cinda Biotech followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.